Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States. [No authors listed] SM Lassman, OM Shopshear, I Jazic, J Ulrich… - BMJ open, 2017 - bmjopen.bmj.com GSID: qY0QiJfSxucJ
Amyloid PET screening for enrichment of early-stage Alzheimer disease clinical trials. Chen T, Suhy J. J Sevigny, J Suhy, P Chiao, T Chen… - Alzheimer Disease & …, 2016 - ingentaconnect.com GSID: kKsxFK5rW-8J
Alzheimer's disease drug development pipeline: 2019. Cummings J, Sabbagh M. J Cummings, G Lee, A Ritter, M Sabbagh… - Alzheimer's & Dementia …, 2019 - Elsevier GSID: 7wsf4B2228IJ